Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer: A Randomized Clinical Trial

IMPORTANCE: Ovarian cancer has the highest mortality rate among gynecologic malignant tumors. Data are lacking on the survival benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in women with ovarian cancer who underwent primary or interval cytoreductive surgery. OBJECTIVE: To assess the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Myong Cheol, Chang, Suk-Joon, Park, Boram, Yoo, Heon Jong, Yoo, Chong Woo, Nam, Byung Ho, Park, Sang-Yoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908225/
https://www.ncbi.nlm.nih.gov/pubmed/35262624
http://dx.doi.org/10.1001/jamasurg.2022.0143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908225/
https://www.ncbi.nlm.nih.gov/pubmed/35262624
http://dx.doi.org/10.1001/jamasurg.2022.0143

Ejemplares similares